[HTML][HTML] Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
Z Xiang, J Liu, D Shi, W Chen, J Li, R Yan… - … Journal of Biological …, 2020 - ncbi.nlm.nih.gov
COVID-19 is a public health emergency that has rapidly spread to over 200 countries and
regions, and no effective treatment has been established to date. Severe and critical cases …
regions, and no effective treatment has been established to date. Severe and critical cases …
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective
AK Singh, S Majumdar, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background and aims Interest in corticosteroid therapy in COVID-19 has been rekindled
after the results from Randomized Evaluation of COVid-19 thERapY (RECOVERY) Trial …
after the results from Randomized Evaluation of COVid-19 thERapY (RECOVERY) Trial …
Management of patients with glucocorticoid-related diseases and COVID-19
I Chifu, M Detomas, U Dischinger, O Kimpel… - Frontiers in …, 2021 - frontiersin.org
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting …
[HTML][HTML] Corticosteroid administration for viral pneumonia: COVID-19 and beyond
JW Yang, L Yang, RG Luo, JF Xu - Clinical Microbiology and Infection, 2020 - Elsevier
Background Corticosteroids are commonly used as adjuvant therapy for acute respiratory
distress syndrome by many clinicians because of their perceived anti-inflammatory effects …
distress syndrome by many clinicians because of their perceived anti-inflammatory effects …
[HTML][HTML] COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
B Russell, C Moss, A Rigg… - …, 2020 - ncbi.nlm.nih.gov
Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information
for clinicians and patients is paramount. There have been a number of reports stating that …
for clinicians and patients is paramount. There have been a number of reports stating that …
Corticosteroids in diabetes patients infected with COVID-19
F Deng, D Gao, X Ma, Y Guo, R Wang, W Jiang… - Irish Journal of Medical …, 2021 - Springer
Coronavirus disease 2019 (COVID-19) has now become a worldwide pandemic, and
infected countries and districts face extraordinary challenges in constraining the rapid …
infected countries and districts face extraordinary challenges in constraining the rapid …
Impact of corticosteroids in coronavirus disease 2019 outcomes: systematic review and meta-analysis
Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …
[PDF][PDF] Corticosteroids for COVID-19: living guidance, 2 September 2020
World Health Organization - 2020 - apps.who.int
Untitled Page 1 Page 2 糖皮质激素用于治疗 2019 冠状 病毒病(COVID-19) 活的指导 2020 年
9 月 2 日 WHO reference number: WHO/2019-nCoV/Corticosteroids/2020.1 © 世界卫生组织 …
9 月 2 日 WHO reference number: WHO/2019-nCoV/Corticosteroids/2020.1 © 世界卫生组织 …
Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients
R Huang, C Zhu, J Wang, L Xue, C Li, X Yan… - European journal of …, 2020 - Elsevier
The impact of corticosteroid treatment on virological course of coronavirus disease 2019
(COVID-19) patients remains unclear. This study aimed to explore the association between …
(COVID-19) patients remains unclear. This study aimed to explore the association between …
What we have to know about corticosteroids use during Sars-Cov-2 infection
Abstract Purpose Glucocorticoids (GCs), alone or associated to other drugs, were widely
used in the management of patients affected by severe acute respiratory syndrome caused …
used in the management of patients affected by severe acute respiratory syndrome caused …